Back to News
Market Impact: 0.12
Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale
Source: Nasdaq
Company Fundamentals
Johnson & Johnson generated higher quarterly revenue than Bristol-Myers Squibb in each of the eight observed quarters, maintaining an uninterrupted lead in total revenue dollars. The comparison indicates J&J's relatively stronger and more consistent revenue scale, but provides no specific revenue figures or new earnings guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
BMY-0.30
JNJ0.35
More News
- JPMorgan initiates Spyre stock with Overweight on IBD pipeline
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- Nike Warns Sales Slump Will Worsen This Fiscal Year
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial